Hosted by Aldevron and MaxCyte at the Leiden Biopark

Join us for an exclusive event hosted by Aldevron and MaxCyte, showcasing capabilities for cell and gene therapy development. Discover innovative solutions to accelerate your research and bring transformative therapies to life.

December 10, 2024
13.15-17.00
Kadans Meeting Room
Plus Ultra Leiden,
Leiden Bio Science Park,
Netherlands

Lunch will be provided. Space is limited, so we encourage you to reserve your spot today.

Presenters

Alicia Roig-Merino, PhD Senior Field Application Scientist, MaxCyte	Maarten Walmagh Business Development Manager, Aldevron
-Development of non-viral T cell therapies -Complex gene editing in hard-to-transfect cells	-Nanoplasmid™ – the power of small -CRISPR-based therapeutics and streamlining the path to commercialization